ART BioScience For Profit
At ART BioScience we are committed to the development of a new class of therapeutics based on messenger RNA (mRNA) for the treatment of Orphan diseases, primarily Duchenne Muscular Dystrophy
Founded Date:
2015-12-01
Headquarters:
Rehovot, HaMerkaz, Israel
Technology:
Drug development
Employee Number:
11-50
Industry:
PharmTech
Estimated Revenue:
000000